

HY-155222 · 1 mg
MedChemExpress · Cat: HY-155222
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/tw9.html
Description
TW9 is a potent dual inhibitor simultaneously targeting BET and HDAC proteins with KDs of 0.069 ?M, 0.231 ?M for BRD4 1 , BRD4 2 , and an IC50 of 0.29 ?M for HDAC1, respectively. TW9 is a newly generated adduct of the BET inhibitor + -JQ1 HY-13030 and class I HDAC inhibitor CI994 HY-50934 . TW9 shows high potency in suppressing tumor growth in pancreatic ductal adenocarcinoma PDAC . TW9 improves the efficacy of the chemotherapeutic agent Gemcitabine HY-17026 .





